PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced that Recursion (NASDAQ: RXRX), a ...

For decades, software developers have been slipping jokes into their work. One of the most enduring, clever, and geekily satisfying inside jokes has been hiding in plain sight: the recursive acronym.

Reports Q4 revenue $4.55M vs. $10.9M last year. “In 2024, Recursion made a transformative leap with the largest TechBio merger in history, combining our pipeline, partnerships, people and ...

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs Platform will ...

Recursion has featured the performance of two generations of proprietary models trained on Recursion’s internal microscopy, Phenom-1 (CVPR 2024) and Phenom-2 (NeurIPS FM4S 2024).

Open-source AI is everywhere right now. The problem is, no one agrees on what it actually is. Now we may finally have an answer. The Open Source Initiative (OSI), the self-appointed arbiters of ...

The C in C-note refers to the Roman numeral for 100, which was printed on $100 bills at one time. The term came to prominence in the 1920s and 1930s, and it was popularized in a number of gangster ...

According to the NIH, obvious symptoms of vitamin C deficiency only occur when a person’s vitamin C intake falls below 10 mg per day for several weeks. This results in scurvy, which is a rare ...

According to the National Academies’ definition, long COVID is a medical condition that persists for at least three months after an infection with SARS-CoV-2, the coronavirus that causes COVID-19.

LONDON, March 11, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced plans to open a new ...

Nvidia Corp. NVDA is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded partnerships Monday with Amgen Inc. AMGN and Recursion Pharmaceuticals Inc ...